Skip to content
Disclosery

MARSHALL WACE, LLP: CRCL position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of MARSHALL WACE, LLP on CRCL, newest first. How the timeline and the estimate are built.

MARSHALL WACE, LLP held 2,901,146 CRCL shares at 2026-06-30 per its 13F-HR filed 2026-08-13.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 2,901,146 shares
    Change vs previous 13F -2,899,204 shares

    0.15% of the 13F portfolio, value $181,698,775.

    13F-HR 0001318757-26-000010 filed by MARSHALL WACE, LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 5,800,350 shares
    Change vs previous 13F -4,178,379 shares

    0.59% of the 13F portfolio, value $553,411,394.

    13F-HR 0001318757-26-000005 filed by MARSHALL WACE, LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 9,978,729 shares
    Change vs previous 13F +1,919,205 shares

    0.76% of the 13F portfolio, value $791,313,210.

    13F-HR 0001318757-26-000003 filed by MARSHALL WACE, LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 8,059,524 shares
    Change vs previous 13F -474,946 shares

    1.17% of the 13F portfolio, value $1,068,531,692.

    13F-HR 0001318757-25-000046 filed by MARSHALL WACE, LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 8,534,470 shares
    Change vs previous 13F not available

    1.84% of the 13F portfolio, value $1,547,214,067.

    13F-HR 0001318757-25-000034 filed by MARSHALL WACE, LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).